Pinz Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Pinz Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,000	Closed	-$301K	–	495
2021 Q3	$301K	Buy	+13,000	New	+$307K	0.14%	82
2021 Q1	–	Sell	-68,000	Closed	-$2.37M	–	394
2020 Q4	$2.37M	Buy	+68,000	New	+$2.96M	1.08%	41
2020 Q3	–	Sell	-29,700	Closed	-$1.38M	–	200
2020 Q2	$1.38M	Buy	+29,700	New	+$1.29M	0.63%	79

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Pinz Capital Management's FMTX Position: Q4 2021 in Review

Pinz Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2021, closing a stake of 13,000 shares — an estimated $301K sold.

Pinz Capital Management first reported a position in FMTX in Q2 2020 and held it in 3 quarters. The position peaked at $2.37M in Q4 2020. 93 funds tracked by Wall St. Rank hold FMTX as of Q4 2021.

Pinz Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Pinz Capital Management sold 13,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2021, an estimated $301K.
Pinz Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Pinz Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.37M in Q4 2020.
93 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2021.

Based on Pinz Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.